BRWA
BLCM

B. Riley Wealth Advisors’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

B. Riley Wealth Advisors’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-11,420
Closed -$4.22K – 1662
2023
Q2 		$4.22K Buy
+11,420
New +$6.16K ﹤0.01% 1534

B. Riley Wealth Advisors's BLCM Position: Q3 2023 in Review

B. Riley Wealth Advisors sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q3 2023, closing a stake of 11,420 shares — an estimated $4.22K sold.

B. Riley Wealth Advisors first reported a position in BLCM in Q2 2023 and held it in 1 quarter. The position peaked at $4.22K in Q2 2023. 0 funds tracked by Wall St. Rank hold BLCM as of Q3 2023.

  • B. Riley Wealth Advisors reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 11,420 Bellicum Pharmaceuticals, Inc. shares in Q3 2023, an estimated $4.22K.
  • B. Riley Wealth Advisors first reported a position in Bellicum Pharmaceuticals, Inc. in Q2 2023 and held it in 1 quarter.
  • B. Riley Wealth Advisors's Bellicum Pharmaceuticals, Inc. position peaked at $4.22K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q3 2023.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2023, filed 1 Dec 2023.